Skip to main content
. 2016 Apr 29;69(2):114–121. doi: 10.4212/cjhp.v69i2.1538

Table 1.

Baseline Demographic Characteristics

Group; No. (%) of Patients or Mean ± SD

Parameter No Heparin (n = 268) Prophylactic Heparin (n = 266) Therapeutic Heparin (n = 13) Overall (n = 547)
Sex, male 158 (59.0) 162 (60.9) 8 (62) 328 (60.0)

Prior transplant loss 33 (12.3) 11 (4.1) 4 (31) 48 (8.8)

Transplant type
  Living 148 (55.2) 134 (50.4) 5 (38) 287 (52.5)
  Deceased donor 120 (44.8) 132 (49.6) 8 (62) 260 (47.5)

Age (years) 50.4 ± 13.1 52.4 ± 13.2 57.5 ± 16.3 51.5 ± 13.3

BMI (kg/m2) 25.7 ± 5.3 26.4 ± 4.7 26.9 ± 5.5 26.1 ± 5.0

Laboratory investigations
  SCr (μmol/L) 546.8 ± 239.5 545.9 ± 261.4 485.0 ± 192.9 544.9 ± 249.2
  Platelets (× 109/L) 177.1 ± 63.2 184.5 ± 57.5 168.9 ± 48.1 180.5 ± 60.2
  Hemoglobin (g/L) 105.8 ± 15.4 104.4 ± 14.5 104.7 ± 12.5 105.1 ± 14.9
  PTT (s) 32.5 ± 8.0 31.65 ± 8.49 40.4 ± 16.6 32.3 ± 8.6
  INR 1.1 ± 0.2 1.09 ± 0.15 1.2 ± 0.1 1.1 ± 0.2

Length of admission (days) 7.8 ± 12.9 8.5 ± 17.4 18.9 ± 17.4 8.3 ± 15.4

Transplant year
  2008–2010 243 (90.7) 14 (5.3) 8 (62) 265 (48.4)
  2011–2013* 25 (9.3) 252 (94.7) 5 (38) 282 (51.6)

Comorbid conditions within 6 months of transplant date
  Diabetes mellitus 82 (30.6) 100 (37.6) 3 (23) 185 (33.8)
  Hypertension 210 (78.4) 229 (86.1) 9 (69) 448 (81.9)
  Malignancy 22 (8.2) 22 (8.3) 2 (15) 46 (8.4)
  Coronary artery disease 52 (19.4) 65 (24.4) 5 (38) 122 (22.3)
  Cerebrovascular events 9 (3.4) 9 (3.4) 0 (0) 18 (3.3)
  Myocardial infarction 11 (4.1) 18 (6.8) 2 (15) 31 (5.7)
  Congestive heart failure 17 (6.3) 14 (5.3) 1 (8) 32 (5.9)
  Dysrhythmia 11 (4.1) 13 (4.9) 1 (8) 25 (4.6)

BMI = body mass index, INR = international normalized ratio, PTT = partial thromboplastin time, SCr = serum creatinine, SD = standard deviation.

*

Up to and including July 31, 2013.